risperidone has been researched along with Acidosis, Diabetic in 10 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess diabetic ketoacidosis risk in patients receiving risperidone or olanzapine." | 7.74 | Risk of diabetic ketoacidosis after exposure to risperidone or olanzapine. ( Kozma, CM; Nasrallah, H; Ramaswamy, K, 2007) |
| "Diagnosed with diabetic ketoacidosis, he was given insulin and saline with discontinuation of all antipsychotics." | 5.34 | New-onset diabetic ketoacidosis induced by the addition of perospirone hydrochloride in a patient treated with risperidone. ( Hamanaka, S; Kamijo, Y, 2007) |
| "We accepted him as type 1 diabetes mellitus (DM type 1)." | 5.33 | Risperidone-associated transient diabetic ketoacidosis and diabetes mellitus type 1 in a patient treated with valproate and lithium. ( Alpaslan, T; Bulent, C; Cengiz, T; Mithat, B, 2005) |
| "A 27-year-old man, who has been using risperidone for two months as the treatment for schizophrenia, with no previous history of diabetes was admitted to the hospital with the presentation of severe diabetes ketoacidosis and subsequent fatal progression." | 3.75 | Risperidone-associated newly diagnosed diabetes and fatal diabetes ketoacidosis in a young schizophrenic patient. ( Lu, CH; Yan, YH, 2009) |
| "To assess diabetic ketoacidosis risk in patients receiving risperidone or olanzapine." | 3.74 | Risk of diabetic ketoacidosis after exposure to risperidone or olanzapine. ( Kozma, CM; Nasrallah, H; Ramaswamy, K, 2007) |
| "Although clozapine and olanzapine have greater diabetes risk, the attributable risk of diabetes mellitus with atypical antipsychotics is small." | 3.72 | Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications. ( Leslie, DL; Rosenheck, RA, 2004) |
| "Data for 60,162 subjects with type 1 diabetes up to the age of 25 years registered in the nationwide German/Austrian Diabetes Survey were included in the analysis." | 1.42 | Comparison of glycemic and metabolic control in youth with type 1 diabetes with and without antipsychotic medication: analysis from the nationwide German/Austrian Diabetes Survey (DPV). ( Bartus, B; Bollow, E; Galler, A; Haberland, H; Holl, RW; Meusers, M; Näke, A; Schober, E, 2015) |
| "Diagnosed with diabetic ketoacidosis, he was given insulin and saline with discontinuation of all antipsychotics." | 1.34 | New-onset diabetic ketoacidosis induced by the addition of perospirone hydrochloride in a patient treated with risperidone. ( Hamanaka, S; Kamijo, Y, 2007) |
| "We accepted him as type 1 diabetes mellitus (DM type 1)." | 1.33 | Risperidone-associated transient diabetic ketoacidosis and diabetes mellitus type 1 in a patient treated with valproate and lithium. ( Alpaslan, T; Bulent, C; Cengiz, T; Mithat, B, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (80.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Galler, A | 1 |
| Bollow, E | 1 |
| Meusers, M | 1 |
| Bartus, B | 1 |
| Näke, A | 1 |
| Haberland, H | 1 |
| Schober, E | 1 |
| Holl, RW | 1 |
| Polcwiartek, C | 1 |
| Vang, T | 1 |
| Bruhn, CH | 1 |
| Hashemi, N | 1 |
| Rosenzweig, M | 1 |
| Nielsen, J | 1 |
| Lu, CH | 1 |
| Yan, YH | 1 |
| Liberty, IF | 1 |
| Todder, D | 1 |
| Umansky, R | 1 |
| Harman-Boehm, I | 1 |
| Ananth, J | 1 |
| Johnson, KM | 1 |
| Levander, EM | 1 |
| Harry, JL | 1 |
| Leslie, DL | 1 |
| Rosenheck, RA | 1 |
| Mithat, B | 1 |
| Alpaslan, T | 1 |
| Bulent, C | 1 |
| Cengiz, T | 1 |
| Hamanaka, S | 1 |
| Kamijo, Y | 1 |
| Ramaswamy, K | 1 |
| Kozma, CM | 1 |
| Nasrallah, H | 1 |
| Sato, Y | 1 |
| Yasui-Furukori, N | 1 |
| Kaneko, S | 1 |
| Moriyama, T | 1 |
2 reviews available for risperidone and Acidosis, Diabetic
| Article | Year |
|---|---|
Diabetic ketoacidosis in patients exposed to antipsychotics: a systematic literature review and analysis of Danish adverse drug event reports.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Glucose; Clozapine; Denmark; Diabe | 2016 |
Atypical antipsychotics and diabetes mellitus: an association.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Diabetes Mellitus; Diabetic Ketoacidosis; Female; | 2004 |
8 other studies available for risperidone and Acidosis, Diabetic
| Article | Year |
|---|---|
Comparison of glycemic and metabolic control in youth with type 1 diabetes with and without antipsychotic medication: analysis from the nationwide German/Austrian Diabetes Survey (DPV).
Topics: Adolescent; Adult; Albuminuria; Antipsychotic Agents; Blood Glucose; Body Mass Index; Diabetes Compl | 2015 |
Risperidone-associated newly diagnosed diabetes and fatal diabetes ketoacidosis in a young schizophrenic patient.
Topics: Adult; Antipsychotic Agents; Diabetes Mellitus; Diabetic Ketoacidosis; Fatal Outcome; Humans; Male; | 2009 |
Diabetic ketoacidosis, neuroleptic malignant syndrome, and myocardial infarction in a patient taking risperidone and lithium carbonate.
Topics: Antipsychotic Agents; Diabetic Ketoacidosis; Drug Therapy, Combination; Humans; Hyperglycemia; Lithi | 2004 |
Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications.
Topics: Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Clozapine; Diabetes Mellitus; Diabetic Ketoa | 2004 |
Risperidone-associated transient diabetic ketoacidosis and diabetes mellitus type 1 in a patient treated with valproate and lithium.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Blood Glucose; Diabetes Mellitus, Type 1; Diabetic Ke | 2005 |
New-onset diabetic ketoacidosis induced by the addition of perospirone hydrochloride in a patient treated with risperidone.
Topics: Adult; Diabetic Ketoacidosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug T | 2007 |
Risk of diabetic ketoacidosis after exposure to risperidone or olanzapine.
Topics: Antipsychotic Agents; Benzodiazepines; California; Diabetic Ketoacidosis; Female; Humans; Incidence; | 2007 |
New-onset diabetic ketoacidosis in a schizophrenic patient with multiple autoimmune disease during treatment with risperidone.
Topics: Antipsychotic Agents; Autoimmune Diseases; Comorbidity; Diabetes Mellitus, Type 1; Diabetic Ketoacid | 2008 |